Business ❯Pharmaceuticals

Drug Development

Drug Development Pharmaceuticals Market Competition Stock Market Clinical Trials Treatment Options Pharmaceuticals Market Trends Drug Development Patient Care

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

AstraZeneca’s partnership with CSPC taps AI to advance chronic disease candidates against a backdrop of ongoing Chinese regulatory scrutiny.

FDA launches AI assistant Elsa early as staff flag readiness issues

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

Novo Nordisk CEO Steps Down Following Share Price Collapse

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

NHS Approves First Daily Pill for Endometriosis Treatment

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

FDA to Decide on First Twice-Yearly HIV Prevention Shot by June

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures